Preliminary evaluation of inactivated antigens as diagnostic controls in molecular detection of vector-borne diseases

Manjini Harshavarthini1, Subbiah Kombiah1,2, Satyendra Pandey1

  • 1ICMR-National Institute of Research in Tribal Health, Jabalpur, India.

PubMed
Abstract

Insights

Inactivated antigens from ELISA kits or slides can serve as reliable positive controls for molecular tests, overcoming challenges with live virus acquisition. This method is valuable for resource-limited settings and emergency diagnostics.

Area of Science:

  • Medical diagnostics
  • Molecular biology
  • Virology

Background:

  • Molecular tests are vital for disease diagnosis.
  • Acquiring live virus controls for molecular testing is difficult due to strict biosafety regulations.
  • An alternative to live virus positive controls is needed.

Purpose of the Study:

  • To evaluate inactivated antigens as positive controls for molecular testing.
  • To provide a viable alternative to live viruses for molecular diagnostic controls.

Main Methods:

  • Inactivated antigens from ELISA kits and microscopic slides were used.
  • Antigens were tested directly and after spiking vector samples.
  • Extracted RNA/DNA from inactivated antigens served as positive controls in RT-PCR/PCR.

Main Results:

  • PCR products of the expected size confirmed successful amplification.
  • Sequencing validated the use of inactivated antigens as controls.
  • Effective as positive controls for Dengue, Chikungunya, Japanese Encephalitis, and Lymphatic Filariasis molecular tests.

Conclusions:

  • Inactivated antigens are suitable positive controls for molecular tests on human and vector samples.
  • This technique offers a practical solution for laboratories in resource-constrained settings.
  • The method is particularly useful during public health emergencies.

Related Concept Videos